Trevin received his BS in chemical engineering in 2018 from the University of Southern California, where he focused on CAR T cell therapy specific to HIV. Since 2018, he's been pursuing a PhD in molecular engineering at the University of Chicago.
In vitro modeling of the immune system and the role of lymphatics in the immune response and cancer.